Hsiao D. Lieu

Insider Reports History

Entity
Individual
Location
C/O Ngm Biopharmaceuticals, Inc., 333 Oyster Point Pkwy, South San Francisco, CA
Signature
/s/ Valerie Pierce, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hsiao D. Lieu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NGM BIOPHARMACEUTICALS INC Chief Medical Officer Common Stock 0 $0 $1.34 Apr 5, 2024 Direct
NGM BIOPHARMACEUTICALS INC Chief Medical Officer Restricted Stock Unit 0 Apr 5, 2024 Direct
NGM BIOPHARMACEUTICALS INC Chief Medical Officer Stock Option (Right to Buy) 0 Apr 5, 2024 Direct

Insider Reports Filed by Hsiao D. Lieu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NGM NGM BIOPHARMACEUTICALS INC Apr 5, 2024 8 $0 4 Apr 8, 2024 Chief Medical Officer
NGM NGM BIOPHARMACEUTICALS INC Jan 16, 2024 1 -$7.28K 4 Jan 18, 2024 EVP, CHIEF MEDICAL OFFICER
NGM NGM BIOPHARMACEUTICALS INC Nov 6, 2023 10 $0 4 Nov 8, 2023 EVP, Chief Medical Officer
NGM NGM BIOPHARMACEUTICALS INC Mar 2, 2023 2 $0 4 Mar 6, 2023 SVP, Chief Medical Officer
NGM NGM BIOPHARMACEUTICALS INC Nov 4, 2022 1 $0 4 Nov 8, 2022 SVP, Chief Medical Officer
NGM NGM BIOPHARMACEUTICALS INC Mar 3, 2022 1 $0 4 Mar 4, 2022 SVP, Chief Medical Officer
NGM NGM BIOPHARMACEUTICALS INC Oct 5, 2021 3 -$19.9K 4 Oct 7, 2021 SVP, Chief Medical Officer
NGM NGM BIOPHARMACEUTICALS INC Aug 11, 2021 4 -$143K 4 Aug 13, 2021 SVP, Chief Medical Officer